| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $117,981,280 | 25 | 100 |
| Partridge Andrew John | Chief Growth Officer | 0 | $0 | 2 | $1.24M | $-1.24M |
| Freidin Aaron | Chief Financial Officer | 0 | $0 | 9 | $10.05M | $-10.05M |
| RAGUSA ROBERT P | Chief Executive Officer | 0 | $0 | 5 | $12.27M | $-12.27M |
| Ofman Joshua J. | President | 0 | $0 | 8 | $14.58M | $-14.58M |
| ILLUMINA, INC. | 10 percent owner | 0 | $0 | 1 | $79.85M | $-79.85M |
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology …
Over the last 12 months, insiders at GRAIL Inc. have bought $0 and sold $117.98M worth of GRAIL Inc. stock.
On average, over the past 5 years, insiders at GRAIL Inc. have bought $0 and sold $75.08M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
| 2026-10-15 | Sale | Ofman Joshua J. | Chief Executive Officer | 20,000 0.0452% | $136.85 | $2.74M | -1.25% | |
| 2026-10-05 | Sale | Freidin Aaron | Chief Financial Officer | 23,619 0.0521% | $146.39 | $3.46M | -10.90% | |
| 2026-10-05 | Sale | Partridge Andrew John | Chief Growth Officer | 7,873 0.0174% | $146.39 | $1.15M | -10.90% | |
| 2026-09-21 | Sale | Ofman Joshua J. | Chief Executive Officer | 61,452 0.1733% | $97.74 | $6.01M | +25.97% | |
| 2026-09-21 | Sale | Freidin Aaron | Chief Financial Officer | 4,100 0.011% | $93.34 | $382,679 | +25.97% | |
| 2026-08-27 | Sale | Ofman Joshua J. | Chief Executive Officer | 5,000 0.012% | $85.02 | $425,098 | +57.34% | |
| 2026-08-27 | Sale | Freidin Aaron | Chief Financial Officer | 7,900 0.0189% | $85.01 | $671,579 | +57.34% | |
| 2026-06-04 | Sale | Partridge Andrew John | Chief Growth Officer | 1,491 0.0032% | $61.08 | $91,070 | +13.46% | |
| 2026-04-08 | Sale | RAGUSA ROBERT P | Chief Executive Officer | 123,502 0.3058% | $49.92 | $6.16M | +38.47% | |
| 2026-04-08 | Sale | Ofman Joshua J. | President | 61,665 0.1527% | $49.92 | $3.08M | +38.47% | |
| 2026-04-08 | Sale | Freidin Aaron | Chief Financial Officer | 45,806 0.1134% | $49.92 | $2.29M | +38.47% | |
| 2026-03-09 | Sale | RAGUSA ROBERT P | Chief Executive Officer | 7,461 0.0182% | $47.89 | $357,296 | +37.62% | |
| 2026-03-09 | Sale | Ofman Joshua J. | President | 2,937 0.0072% | $47.89 | $140,650 | +37.62% | |
| 2026-03-09 | Sale | Freidin Aaron | Chief Financial Officer | 2,492 0.0061% | $47.89 | $119,340 | +37.62% | |
| 2026-03-05 | Sale | RAGUSA ROBERT P | Chief Executive Officer | 980 0.0026% | $53.01 | $51,950 | +32.03% | |
| 2026-03-05 | Sale | Ofman Joshua J. | President | 690 0.0018% | $53.01 | $36,577 | +32.03% | |
| 2026-03-05 | Sale | Freidin Aaron | Chief Financial Officer | 655 0.0017% | $53.01 | $34,722 | +32.03% | |
| 2026-03-02 | Sale | RAGUSA ROBERT P | Chief Executive Officer | 37,504 0.0907% | $50.17 | $1.88M | +29.69% | |
| 2026-03-02 | Sale | Ofman Joshua J. | President | 17,002 0.0411% | $50.16 | $852,848 | +29.69% | |
| 2026-03-02 | Sale | Freidin Aaron | Chief Financial Officer | 9,573 0.0231% | $50.17 | $480,244 | +29.69% |
| Increased Positions | 235 | +64.38% | 8M | +33.97% |
| Decreased Positions | 140 | -38.36% | 3M | -13.41% |
| New Positions | 112 | New | 3M | New |
| Sold Out Positions | 43 | Sold Out | 537,007 | Sold Out |
| Total Postitions | 460 | +26.03% | 30M | +20.56% |